Scientists on the Icahn Faculty of Medication at Mount Sinai have created a brand new synthetic intelligence device that may each discover genetic mutations that trigger illness and predict what sorts of diseases these mutations are prone to result in. The strategy, known as V2P (Variant to Phenotype), is meant to hurry up genetic testing and help […]
Source link











